Articles From: Alcobra Ltd. Submits Protocol to FDA for Phase IIb Clinical Study of Metadoxine Extended Release (MDX) in the Treatment of Fragile X Syndrome to Alere Inc. Announces Third Quarter 2013 Results


2014/4/10
TEL AVIV, Israel, April 10, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd.
Sign-up for Alcobra Ltd. Submits Protocol to FDA for Phase IIb Clinical Study of Metadoxine Extended Release (MDX) in the Treatment of Fragile X Syndrome investment picks
2014/2/24
TEL AVIV, Israel, Feb.
Sign-up for Alcobra Ltd. to Discuss Biomarkers in Fragile X and Autism Trials at the Second Annual Autism Investment Conference investment picks
2013/10/31
TEL AVIV, Israel, Oct.
Sign-up for Alcobra Ltd. to Host a Third Quarter 2013 Conference Call on November 7th investment picks
2013/7/30
TEL AVIV, Israel, July 30, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd.
Sign-up for Alcobra Ltd. to Host ADHD Seminar in New York City on August 6, 2013 investment picks
2013/10/21
TEL AVIV, Israel, Oct.
Sign-up for Alcobra Ltd. to Present at AACAP's 60th Annual Meeting on October 24th investment picks
2013/9/3
TEL AVIV, Israel, Sept.
Sign-up for Alcobra Ltd. to Present at the Stifel Nicolaus 2013 Annual Healthcare Conference on September 11th investment picks
2014/1/31
TEL AVIV, Israel, Jan.
Sign-up for Alcobra Ltd. to Provide Corporate Overview at 16th Annual BIO CEO & Investor Conference investment picks
TEL AVIV, Israel, July 24, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd.
Sign-up for Alcobra Ltd. to Provide Second Quarter 2013 Financials and Business Update on August 6th investment picks
2014/1/29
TEL AVIV, Israel, Jan.
Sign-up for Alcobra Ltd. to Release Fourth Quarter 2013 Results and Host Investor Conference Call on Thursday, February 13, 2014 investment picks
2014/1/13
Led Efforts to Build Shire's Pipeline of ADHD and CNS Products Launched Vyvanse ® , the #1 ADHD Brand in the U.S. Brand management experience on five different billion dollar brands across three therapeutic categories TEL AVIV, Israel, Jan.
Sign-up for Alcobra Strengthens Management Team With Addition of Industry Veteran David C. Baker as Chief Commercial Officer investment picks
--Last patient visit scheduled for November 26, 2013 TEL AVIV, Israel, Nov.
Sign-up for Alcobra Successfully Completes Enrollment in Comparative Phase II Study of Attention and Cognitive Function Benefits in Patients With PI-ADHD investment picks
TEL AVIV, Israel, Dec.
Sign-up for Alcobra to Present at the 25th Annual Piper Jaffray Healthcare Conference investment picks
2013/9/25
TEL AVIV, ISRAEL, Sept.
Sign-up for Alcobra to Present Fragile X Study Results at 2013 FRAXA Investigators Meeting investment picks
2013/9/10
TEL AVIV, Israel, Sept.
Sign-up for Alcobra's Pre-Clinical Fragile X Study for MG01CI Shows Significant Positive Results investment picks
2013/10/29
NAO Robot Delivers Truly Natural and Conversational Interactions with Nuance's Powerful Voice Recognition and Text-to-Speech, Driving the Future of Human-Robot Communication PARIS and BURLINGTON, Massachusetts , October 29, 2013 /PRNewswire/ -- Aldebaran Robotics and Nuance Communications, Inc, (NASDAQ: NUAN) today announced that Aldebaran's renowned NAO Robot will integrate Nuance's conversational voice capabilities to deliver a more natural and compelling experience between humans and robots.
Sign-up for Aldebaran Robotics and Nuance Revolutionize Human - Machine Interaction investment picks
2014/3/19
By Michael Calia Alder Biopharmaceuticals Inc. filed for an initial public offering of up to $115 million in common stock, as the company looks to fund product development.
Sign-up for Alder Biopharmaceuticals Files for IPO of Up to $115 Million investment picks
2014/3/27
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0935764001&sourceType=1 http://www.ccnmatthews.com/logos/20111003-advlogful.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Alderon Signs Agreement with the Town of Wabush and Receives Permission for Mineral Extraction investment picks
By Ian Walker LONDON--Discount retailer Aldi posted another record rise in market share in the 12 weeks ended Oct.
Sign-up for Aldi Posts Record Market Share Rise as Campaigns Attract New Shoppers investment picks
2014/1/14
By Ian Walker LONDON--Discount retailers Aldi and Lidl, together with high-end supermarket Waitrose were the clear winners in the Christmas sales war, while J.
Sign-up for Aldi, Lidl and Waitrose Win Christmas Sales War investment picks
By Ian Walker LONDON--Discount retailer Aldi and upmarket chain Waitrose both showed record market shares in the latest data Tuesday, while former darling of the sector Tesco PLC (TSCO.LN) saw its share fall to its lowest level since late 2004 in an increasingly cut-throat environment.
Sign-up for Aldi, Waitrose Market Shares at Record Levels, Tesco's Lowest Since 2004 - Kantar investment picks
PureSystems helps reduce power consumption and software licensing costs SAO PAULO , Dec.
Sign-up for Alelo Consolidates Data Center and Prepares for the Cloud with IBM PureSystems investment picks
2013/12/18
Alere Analytics, an Alere subsidiary specializing in analytics and Clinical Decision Support (CDS) technology, announces that its Clinical Quality Measures (CQM) Services version 2.1 and Public Health Electronic Laboratory Reporting (ELR) and Communication Portal version 3.2 have been tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program.
Sign-up for Alere Analytics Clinical Quality Measures and Electronic Laboratory Reporting Receive ONC-ACB Drummond Group Certification for Meaningful Use investment picks
2013/8/8
Alere Analytics , an Alere subsidiary specializing in healthcare analytics and clinical decision support (CDS) technology, today announced the availability of its Electronic Laboratory Reporting (ELR) Solution to assist hospitals with submitting reportable lab results to State Departments of Health.
Sign-up for Alere Analytics Launches Electronic Laboratory Reporting (ELR) Solution to Help Hospitals Automate Public Health Submissions and Satisfy Meaningful Use Requirements investment picks
Alere Analytics , an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced that Chief Medical Officer and Co-founder, Dr.
Sign-up for Alere Analytics Provides Healthcare Insights on the Future of Patient Engagement at the 2013 NEHI Innovation Conference investment picks
2013/8/7
WALTHAM, Mass.
Sign-up for Alere Announces Preliminary Results Of Voting At Annual Meeting investment picks
WALTHAM, Mass.
Sign-up for Alere Enhances Board of Directors With Appointment Of Gregg J. Powers investment picks
2014/2/6
WALTHAM, Mass.
Sign-up for Alere Inc. Announces Fourth Quarter 2013 Results investment picks
WALTHAM, Mass.
Sign-up for Alere Inc. Announces Second Quarter 2013 Results investment picks
WALTHAM, Mass.
Sign-up for Alere Inc. Announces Third Quarter 2013 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Alcobra Ltd. Submits Protocol to FDA for Phase IIb Clinical Study of Metadoxine Extended Release (MDX) in the Treatment of Fragile X Syndrome to Alere Inc. Announces Third Quarter 2013 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity